Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 1;151(2):e2022060179.
doi: 10.1542/peds.2022-060179.

Mpox in Children and Adolescents: Epidemiology, Clinical Features, Diagnosis, and Management

Amy M Beeson  1   2 , Julia Haston  1 , David W McCormick  1 , Mary Reynolds  1 , Kevin Chatham-Stephens  1 , Andrea M McCollum  1 , Shana Godfred-Cato  1
Affiliations
Review

Mpox in Children and Adolescents: Epidemiology, Clinical Features, Diagnosis, and Management

Amy M Beeson et al. Pediatrics. .

Abstract

Although mpox is rare among children in the United States, pediatric cases are being reported during the 2022 multinational mpox outbreak. Vaccines and antiviral medications developed for other orthopoxviruses have recently become widely used to prevent and treat mpox in both children and adults in the United States. Although scientific literature regarding mpox in children and adolescents is scant, prior case reports can provide valuable information about the clinical features and potential complications of untreated clade II mpox in these age groups. In this review, we summarize the epidemiology and clinical features of mpox in children and adolescents and provide recommendations for clinicians regarding its diagnosis, management, and prevention. Robust, dedicated surveillance of pediatric exposures and cases in the current outbreak, including the use of vaccines and therapeutics, are needed to guide clinical management and public health strategies.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no conflicts of interest to disclose. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Center for Disease Control and Prevention.

Figures

FIGURE 1
FIGURE 1
Mpox photos. Clinical photographs depicting an early vesicle (1A), umbilicated pustule (1B), ulcerated lesion (1C), and diffuse pustular rash (1D). 1A, 1B, 1C image credit: UK Health Security Agency. 1D image credit: NHS England High Consequence Infectious Diseases Network.
FIGURE 2
FIGURE 2
Epidemiologic criteria. See https://www.cdc.gov/poxvirus/monkeypox/clinicians/case-definition.html for Case Definitions for Use in the 2022 Mpox Response.
See this image and copyright information in PMC

References

    1. World Health Organization. 2022 monkeypox outbreak: global trends. Available at: https://worldhealthorg.shinyapps.io/mpx_global/. Accessed November 1, 2022
    1. Centers for Disease Control and Prevention. Monkeypox vaccine administration in the U.S. Available at: https://www.cdc.gov/poxvirus/monkeypox/response/2022/vaccines_data.html. Accessed November 1, 2022
    1. Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox-a potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16(2):e0010141. - PMC - PubMed
    1. Mbala PK, Huggins JW, Riu-Rovira T, et al. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J Infect Dis. 2017;216(7):824–828 - PubMed
    1. Hutson CL, Carroll DS, Gallardo-Romero N, et al. Monkeypox disease transmission in an experimental setting: prairie dog animal model. PLoS One. 2011;6(12): e28295. - PMC - PubMed

Substances